SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
SEC Accession No. 0001193125-11-068867
Filing Date
2011-03-16
Accepted
2011-03-16 17:25:00
Documents
10
Period of Report
2010-12-31
Filing Date Changed
2011-03-16

Document Format Files

Seq Description Document Type Size
1 FORM 10-K d10k.htm 10-K 2906102
2 EXECUTIVE EMPLOYMENT AGREEMENT - STEVE BRYANT dex1030.htm EX-10.30 245243
3 STATEMENT RE COMPUTATION OF RATIOS dex12.htm EX-12 29764
4 LIST OF WORLDWIDE SUBSIDIARIES dex21.htm EX-21 10653
5 CONSENT OF PRICEWATERHOUSECOOPERS LLP dex231.htm EX-23.1 1514
6 CERTIFICATION OF CEO PURSUANT TO SECTION 302 dex311.htm EX-31.1 10293
7 CERTIFICATION OF CFO PURSUANT TO SECTION 302 dex312.htm EX-31.2 10293
8 CERTIFICATION OF CEO PURSUANT TO SECTION 906 dex321.htm EX-32.1 3608
9 CERTIFICATION OF CFO PURSUANT TO SECTION 906 dex322.htm EX-32.2 3803
10 GRAPHIC g162183g26b76.jpg GRAPHIC 68615
  Complete submission text file 0001193125-11-068867.txt   3316795
Mailing Address
Business Address 1618 STATION STREET VANCOUVER A1 V6A 1B6
ANGIOTECH PHARMACEUTICALS INC (Filer) CIK: 0001096481 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-30334 | Film No.: 11692895
SIC: 3841 Surgical & Medical Instruments & Apparatus
Assistant Director 10